During the past decade, City Clinical Hospital # 21 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "City Clinical Hospital # 21" are "Crohn Disease" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "City Clinical Hospital # 21" in a lesser frequency.

Most popular intervention types in "City Clinical Hospital # 21" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab (40 mg)" (1 trials), "Guselkumab" (1 trials), "Placebo" (1 trials), "Placebo for Adalimumab" (1 trials) and "Placebo for Ustekinumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "City Clinical Hospital # 21" are 2 trials for "All" genders.

Currently, there are NaN active trials in "City Clinical Hospital # 21". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in City Clinical Hospital # 21, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in City Clinical Hospital # 21, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".